Resource Library

Plan 4 PrEP: Step 5: Facility Readiness Assessment

Service Delivery

Health Care Providers as Agents of Change: Integrating PrEP with other sexual and reproductive health services for adolescent girls and young women

Providing integrated HIV PrEP and sexual reproductive health (SRH) care is difficult for many healthcare providers. They face many barriers. Successul integration will require interation and adaptation. O'Malley et al. investigate the structural and motivational barriers that healthcare providers face in providing integrated care to adolescent girls and young women (AGYW).

Research, Service Delivery

A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa

This study explores the feasibility and acceptability of providing PrEP to adolescent girls and young women via a community-based mobile health clinic known as the Tutu Teen Truck in Cape Town, South Africa

Research, Service Delivery

Sexually Transmitted Infections Among African Women: An opportunity for combination sexually transmitted infection/HIV prevention

The global epidemic of Sexually Transmitted Infections (STIs) in women demands new prevention approaches. This article outlines new strategies which are emerging that offer opportunities for research and program delivery of combination STI/HIV prevention .

Research

Project Hope Namibia PrEP Communication Toolkit

Duplicated resource, same as above

Demand Creation/Marketing

Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa

This study compares the effectiveness and cost-effectiveness of providing antiretroviral therapy vs PrEP in South Africa

Financing & Costing

Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa

This study estimates the cost-effectiveness of daily oral PrEP, with a protective effect against the herpes simplex virus as well as HIV, among HIV serodifferent couples in South Africa

Financing & Costing

FDA approves first drug for reducing the risk of sexually acquired HIV infection

This article from July 16, 2012 announces the U.S. Food and Drug Administration's approval of Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners.

Normative Guidance/Policies

From Proof-of-Concept to Prevention Phenomenon in Five Years

This timeline, first appearing in AVAC Report 2014/15: HIV Prevention on the Line, shows PrEP going from proof-of-concept to prevention phenomenon in five years and can be used to anticipate and speed action on the next generation of ARV-based prevention options.

Research

Oral PrEP Training for Providers

This modifiable training slide deck was developed with support from USAID and PEPFAR through the Meeting Targets and Maintaining Epidemic Control (EpiC) project. The materials reflect WHO guidance as of 4 April 2022 and build on lessons learned from nearly ten years of oral PrEP implementation. The training is built so that it can be…

Service Delivery